Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...

Proprietary Insights – Stifel Discover delivers exclusive analysis and commentary from Stifel’s Chief Investment Officer, Chief Economist, Chief Washington Policy Strategist, equity research analysts, ...

Stifel analysts reaffirmed their Buy rating on Generac Holdings (NYSE:GNRC) with a consistent price target of $210.00. Currently trading at $145.07 with a market capitalization of $8.63 billion, ...

In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report), ...

Ron Kruszewski, Stifel's chairman and CEO, told financial analysts that its investment banking franchise is well-positioned ...

Good day and welcome to the Stifel Financial fourth quarter financial results conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr Joel ...

Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services ...

On Monday, Stifel analysts maintained a Buy rating on ServiceTitan stock (NASDAQ:TTAN) with a steady price target of $120.00. The company, currently trading at $92.56 with a market capitalization ...